Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus

Pharmaceutics. 2021 May 7;13(5):672. doi: 10.3390/pharmaceutics13050672.

Abstract

Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro- and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in E. coli a fusion protein consisting of large extracellular loop of CD81 receptor and streptavidin as spacing part. The obtained protein has been immobilized on the surface of PLA-based micro- and nanoparticles. The developed trapping systems were characterized in terms of their physico-chemical properties. In order to illustrate the ability of developed micro- and nanotraps to bind HCV, E2 core protein of HCV was synthesized as a fusion protein with GFP. Interaction of E2 protein and hepatitis C virus-mimicking particles with the developed trapping systems were testified by several methods.

Keywords: interaction of LEL CD81 with E2 protein; poly(lactic acid)-based micro- and nanoparticles; recombinant CD81-streptavidin fusion protein; trapping system for HCV; virus-mimicking particles.